NCT01742884View on ClinicalTrials.gov

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Moderate Dry Eye Syndrome
Interventions
OTHER

Thealoz

Instillation of 1 drop of Thealoz

OTHER

Vehicle

1 drop of the vehicle will be instillated in the eye

Trial Locations (1)

47011

IOBA - University of Valladolid, Valladolid

All Listed Sponsors
lead

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

NCT01742884 - Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz | Biotech Hunter | Biotech Hunter